An immunoblot analysis of EpCAM, E-cadherin (known epithelial cell markers), and vimentin (known mesenchymal cell markers) was performed to determine the effect of PYCR2 upon cancer cell phenotype [39,40,41]. Here, PYCR2 is linked to cancer.